Sign in
4/A

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-22-000051

Chief Operating Officer sold 577 shares at $2.03 ($1,170)

From the SEC's structured data for this filing

Trades in this filing

Miller Matthew P · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-11-15 Sale : show line 1 in the form −577 $2.03 $1,170 78,034 D
Open-market sales · 577 sh · avg $2.03 · $1,170
Loading xslF345X03/edgardoc.xml…